Literature DB >> 14747226

Comparison of the [13C]glucose breath test to the hyperinsulinemic-euglycemic clamp when determining insulin resistance.

Richard Z Lewanczuk1, Breay W Paty, Ellen L Toth.   

Abstract

OBJECTIVE: With increasing emphasis on the recognition of the metabolic syndrome and early type 2 diabetes, a clinically useful measure of insulin resistance is desirable. The purpose of this study was to evaluate whether an index of glucose metabolism, as measured by (13)CO(2) generation from ingested [(13)C]glucose, would correlate with indexes from the hyperinsulinemic-euglycemic clamp. RESEARCH DESIGN AND METHODS: A total of 26 subjects with varying degrees of insulin sensitivity underwent both the [(13)C]glucose breath test and the hyperinsulinemic-euglycemic clamp. Results from the [(13)C]glucose breath test were compared with measures of insulin sensitivity from the glucose clamp as well as with other commonly used indexes of insulin sensitivity.
RESULTS: There was a strong correlation between the [(13)C]glucose breath test result and the glucose disposal rate (r = 0.69, P < 0.0001) and insulin sensitivity index (r = 0.69, P < 0.0001) from the insulin clamp. The magnitude of these correlations compared favorably with QUICKI and were superior to the homeostasis model assessment.
CONCLUSIONS: The [(13)C]glucose breath test may provide a useful noninvasive assessment of insulin sensitivity.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14747226     DOI: 10.2337/diacare.27.2.441

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  9 in total

1.  [13C]glucose breath testing provides a noninvasive measure of insulin resistance: calibration analyses against clamp studies.

Authors:  Maysa Hussain; Morteza Jangorbhani; Sally Schuette; Robert V Considine; Robin L Chisholm; Kieren J Mather
Journal:  Diabetes Technol Ther       Date:  2013-10-11       Impact factor: 6.118

2.  Intra-individual variability of CO₂ breath isotope enrichment compared to blood glucose in the oral glucose tolerance test.

Authors:  Pooja Singal; Morteza Janghorbani; Sally A Schuette; Robin Chisholm; Kieren J Mather
Journal:  Diabetes Technol Ther       Date:  2010-12       Impact factor: 6.118

3.  Development of minimally invasive 13C-glucose breath test to examine different exogenous carbohydrate sources in patients with glycogen storage disease type Ia.

Authors:  Abrar Turki; Sylvia Stockler; Sandra Sirrs; Ramona Salvarinova; Gloria Ho; Jennifer Branov; Annie Rosen-Heath; Taryn Bosdet; Rajavel Elango
Journal:  Mol Genet Metab Rep       Date:  2022-05-11

4.  Novel noninvasive breath test method for screening individuals at risk for diabetes.

Authors:  E Lichar Dillon; Morteza Janghorbani; James A Angel; Shanon L Casperson; James J Grady; Randall J Urban; Elena Volpi; Melinda Sheffield-Moore
Journal:  Diabetes Care       Date:  2008-12-15       Impact factor: 19.112

5.  Assessment of insulin resistance by a 13C glucose breath test: a new tool for early diagnosis and follow-up of high-risk patients.

Authors:  Meir Mizrahi; Gadi Lalazar; Tomer Adar; Itamar Raz; Yaron Ilan
Journal:  Nutr J       Date:  2010-05-27       Impact factor: 3.271

6.  Insulin sensitivity index (ISI0, 120) potentially linked to carbon isotopes of breath CO2 for pre-diabetes and type 2 diabetes.

Authors:  Chiranjit Ghosh; Prabuddha Mukhopadhyay; Shibendu Ghosh; Manik Pradhan
Journal:  Sci Rep       Date:  2015-07-07       Impact factor: 4.379

7.  The 13C-Glucose Breath Test for Insulin Resistance Assessment in Adolescents: Comparison with Fasting and Post-Glucose Stimulus Surrogate Markers of Insulin Resistance.

Authors:  Jorge Maldonado-Hernández; Azucena Martínez-Basila; Alejandra Salas-Fernández; José R Navarro-Betancourt; Mónica I Piña-Aguero; Mariela Bernabe-García
Journal:  J Clin Res Pediatr Endocrinol       Date:  2016-06-29

Review 8.  European guideline on indications, performance and clinical impact of 13 C-breath tests in adult and pediatric patients: An EAGEN, ESNM, and ESPGHAN consensus, supported by EPC.

Authors:  Jutta Keller; Heinz F Hammer; Paul R Afolabi; Marc Benninga; Osvaldo Borrelli; Enrique Dominguez-Munoz; Dan Dumitrascu; Oliver Goetze; Stephan L Haas; Bruno Hauser; Daniel Pohl; Silvia Salvatore; Marc Sonyi; Nikhil Thapar; Kristin Verbeke; Mark R Fox
Journal:  United European Gastroenterol J       Date:  2021-06-14       Impact factor: 4.623

9.  Estimation of Insulin Resistance in Mexican Adults by the [(13)C]Glucose Breath Test Corrected for Endogenous Total CO(2) Production.

Authors:  Erika Ibarra-Pastrana; Maria Del Carmen Candia Plata; Gerardo Alvarez; Mauro E Valencia
Journal:  Int J Endocrinol       Date:  2012-07-17       Impact factor: 3.257

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.